Skip to content

US · ALPS · BIOTECHNOLOGY

Alps Group Inc (ALPS) intrinsic value and stock valuation

$1.15as of 2026-11-21 · Mkt cap 66.98M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Alps Group Inc DCF and intrinsic value

InvestorsCraft values ALPS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ALPS’s statements →

Alps Group Inc Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Kuala Lumpur, WP 50400 alps-holdings.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$3.37M
20212025
Net income
-$-67.57M
20212025
Free cash flow
-$-1.69M
20212025
Total equity
-$-1.12M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$3.37M$2.4M—$3.59M$0.00
Operating income-$-66.85M-$-2.36M—-$-540K-$-140K
Net income-$-67.57M-$-2.3M—-$-730K-$-120K
EPSd-$-14.66M-$-382.7K—-$-13.62K-$-2.24K
Operating cash flow-$-1.61M-$-1.37M-$-110K—-$-320K
Capital expenditure-$-80K-$-220K-$-270K—$0.00
Free cash flow-$-1.69M-$-1.59M-$-390K—-$-320K
Total assets$7.13M$6.7M—$119.2M$118M
Total debt$960K$510K—$0.00$0.00
Net debt$640K$50K—-$-80K-$-810K
Total equity-$-1.12M$1.45M—$113.8M$113.6M
Cash and short-term investments$320K$460K—$80K$810K
Income statement
2025202420222021
Revenue$3.37M$2.4M$3.59M$0.00
Cost of revenue$2.07M$1.8M$1.62M$0.00
Gross profit$1.3M$600K$1.98M$0.00
Research and development expenses$0.00$280K$0.00$0.00
Selling, general and administrative expenses$66.8M$1.7M$26.1M$140K
Other expenses$1.38M$970K-$-23.58M$0.00
Operating expenses$68.2M$2.95M$2.51M$140K
Cost and expenses$70.2M$4.76M$4.13M$140K
Interest income$0.00$0.00$0.00$0.00
Interest expense$490K$40K$50K$0.00
Depreciation and amortization$0.00$900K$900K$0.00
Ebitda-$-66.93M-$-1.45M$360K-$-120K
Operating income-$-66.85M-$-2.36M-$-540K-$-140K
Total other income/expenses, net-$-570K-$-40K-$-50K$20K
Income before tax-$-67.42M-$-2.4M-$-580K-$-120K
Income tax expense$260K-$-10K$150K$0.00
Net income-$-67.57M-$-2.3M-$-730K-$-120K
Weighted average shares outstanding$4.61M$6.01M$34.5M$34.5M
Weighted average diluted shares outstanding$4.61M$6.01M$53.6M$53.6M
Balance sheet
2025202420222021
Cash and short-term investments$320K$460K$80K$810K
Net receivables$440K$230K$240K$0.00
Inventory$560K$360K$0.00$0.00
Total current assets$1.49M$1.28M$530K$1.03M
Property, plant and equipment, net$3.32M$3.07M$0.00$0.00
Goodwill and intangible assets$730K$840K$200K$0.00
Long-term investments$1.6M$1.51M$118.4M$116.7M
Total non-current assets$5.64M$5.42M$118.7M$116.9M
Total assets$7.13M$6.7M$119.2M$118M
Accounts payable$320K$180K$0.00$0.00
Short-term debt$220K$310K$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00
Total current liabilities$7.49M$5.06M$810K$230K
Long-term debt$740K$190K$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00
Total non-current liabilities$760K$190K$4.03M$4.14M
Capital lease obligations$960K$510K$0.00$0.00
Total liabilities$8.25M$5.25M$4.84M$4.37M
Common stock$0.00$13.5M$117.9M$116.7M
Retained earnings-$-11.17M-$-8.65M-$-4.06M-$-3.14M
Accumulated other comprehensive income (loss)$10.3M-$-3.31M$0.00$0.00
Total equity-$-1.12M$1.45M$113.8M$113.6M
Total investments$1.6M$1.51M$118.4M$116.7M
Total debt$960K$510K$0.00$0.00
Net debt$640K$50K-$-80K-$-810K
Cash flow statement
2025202420232021
Net income-$-2.53M-$-2.4M-$-580K-$-120K
Depreciation and amortization$1.13M$900K$900K$0.00
Stock-based compensation$0.00$0.00$0.00$0.00
Change in working capital-$-160K$190K-$-390K-$-190K
Accounts receivable-$-30K-$-30K$100K$0.00
Inventory-$-190K$30K$220K$0.00
Accounts payable$150K$50K-$-10K$0.00
Net cash provided by operating activities-$-1.61M-$-1.37M-$-110K-$-320K
Investments in property, plant and equipment-$-80K-$-220K-$-270K$0.00
Acquisitions, net$0.00-$-1.49M-$0.00$0.00
Net cash used for investing activities-$-820K-$-1.71M-$-290K-$-116.72M
Common stock issued$0.00$2.3M$0.00$117.9M
Common stock repurchased-$-26.89M$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00
Net cash used for financing activities$4.37M$3.28M$210K$117.9M
Net change in cash$1.64M$200K-$-210K$810K
Cash at end of period$2.1M$460K$260K$810K
Operating cash flow-$-1.61M-$-1.37M-$-110K-$-320K
Capital expenditure-$-80K-$-220K-$-270K$0.00
Free cash flow-$-1.69M-$-1.59M-$-390K-$-320K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Alps Group Inc

        Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

        CEO
        Seng Kong Tham
        Employees
        2
        Beta
        -0.06

        Explore

        Frequently asked questions

        What is the intrinsic value of Alps Group Inc (ALPS)?

        InvestorsCraft does not currently publish an intrinsic value for ALPS. How the IC value is calculated.

        Is ALPS undervalued?

        InvestorsCraft does not publish an undervaluation signal for ALPS at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.